Q4 2015

Source filing unavailable

Q4 2015 · —

Revenue

$0.00

derivedno prior Q4 2014 on file

Net Income

-$158.00K

no prior Q4 2014 on file

EPS Diluted

$0.00

no prior Q4 2014 on file

Operating Income-$151,000—

Operating Cash Flowderived-$106,000—

Same quarter

no prior Q4 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR